Skip to main content

PositiveID announces partnerships with DRI, Schneider Children's


DELRAY BEACH, Fla. — In an effort to continue developing and studying its diabetes management products, PositiveID has teamed up with the Diabetes Research Institute at the University of Miami and Schneider Children's Medical Center of Israel.

"We believe that joining forces with the DRI and Schneider Children's, two of the world's foremost diabetes research organizations, will enable us to accelerate the remaining development and study of our noninvasive diabetes management projects, and ultimately bring these groundbreaking products to market," PositiveID chairman and CEO William Caragol said.

PositiveID currently is developing Easy Check, a noninvasive breath glucose detection device; GlucoChip, a continuous glucose-sensing microchip; and the iGlucose glucometer, a blood-glucose meter with PositiveID's Food and Drug Administration-cleared iGlucose technology built inside the device.

Interested in this topic? Sign up for our weekly Collaborative Care e-newsletter.

This ad will auto-close in 10 seconds